Roberta Gonella

465 total citations
17 papers, 257 citations indexed

About

Roberta Gonella is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Roberta Gonella has authored 17 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Roberta Gonella's work include Hematopoietic Stem Cell Transplantation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Neutropenia and Cancer Infections (4 papers). Roberta Gonella is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Neutropenia and Cancer Infections (4 papers). Roberta Gonella collaborates with scholars based in Italy and United States. Roberta Gonella's co-authors include Alberto Ballestrero, Franco Patrone, Luciano Ottonello, C. Sacchetti, Franco Dallegri, Patrizia Dapino, Anna Garuti, Fabio Ferrando, S Nati and Potito Rosario Scalzulli and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Roberta Gonella

17 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Gonella Italy 10 115 80 61 61 37 17 257
Ekaterina A. Alekseeva Russia 8 64 0.6× 33 0.4× 108 1.8× 43 0.7× 26 0.7× 21 287
Koichi Onodera Japan 11 67 0.6× 79 1.0× 63 1.0× 40 0.7× 38 1.0× 38 264
M.D. Minden Canada 7 52 0.5× 86 1.1× 152 2.5× 41 0.7× 23 0.6× 16 289
Maki Kitano United States 7 52 0.5× 71 0.9× 83 1.4× 64 1.0× 10 0.3× 8 225
Adam Walter‐Croneck Poland 10 130 1.1× 174 2.2× 110 1.8× 39 0.6× 20 0.5× 32 276
Weiying Gu China 10 76 0.7× 58 0.7× 95 1.6× 58 1.0× 8 0.2× 35 247
M. H. Le United States 6 140 1.2× 31 0.4× 91 1.5× 20 0.3× 11 0.3× 9 275
Eleonora Zanetti Italy 10 80 0.7× 22 0.3× 77 1.3× 34 0.6× 8 0.2× 29 253
K Hirashima Japan 11 70 0.6× 152 1.9× 128 2.1× 177 2.9× 71 1.9× 34 419
S. Muthuramalingam United Kingdom 6 190 1.7× 16 0.2× 85 1.4× 137 2.2× 16 0.4× 10 346

Countries citing papers authored by Roberta Gonella

Since Specialization
Citations

This map shows the geographic impact of Roberta Gonella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Gonella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Gonella more than expected).

Fields of papers citing papers by Roberta Gonella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Gonella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Gonella. The network helps show where Roberta Gonella may publish in the future.

Co-authorship network of co-authors of Roberta Gonella

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Gonella. A scholar is included among the top collaborators of Roberta Gonella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Gonella. Roberta Gonella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferrando, Lorenzo, Gabriella Cirmena, Anna Garuti, et al.. (2020). Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma. PLoS ONE. 15(2). e0226595–e0226595. 18 indexed citations
2.
Cirmena, Gabriella, Anna Garuti, Marilena De Mariano, et al.. (2020). Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Journal of Oncology. 2020. 1–10. 3 indexed citations
3.
Capitanio, Selene, Francesca Bongioanni, Arnoldo Piccardo, et al.. (2016). Comparisons between glucose analogue 2-deoxy-2-(18F)fluoro-D-glucose and18F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions. World Journal of Radiology. 8(2). 200–200. 14 indexed citations
4.
Piccardo, Arnoldo, Matteo Puntoni, Silvia Morbelli, et al.. (2015). 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT. Nuklearmedizin - NuclearMedicine. 54(4). 163–172. 19 indexed citations
5.
Murialdo, Roberto, Monica Gallo, Gabriele Zoppoli, et al.. (2014). Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes.. PubMed. 100(2). 128–35. 2 indexed citations
6.
Murialdo, Roberto, Monica Gallo, Gabriele Zoppoli, et al.. (2014). Sequential Dose-dense 5-fluorouracil, Epirubicin and Cyclophosphamide Followed by Docetaxel in Patients with Early Breast Cancer with Four or more Positive Lymph Nodes. Tumori Journal. 100(2). 128–135. 3 indexed citations
8.
Ballestrero, Alberto, Roberta Gonella, Maurizio Miglino, et al.. (2007). Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. Annals of Hematology. 87(1). 49–55. 21 indexed citations
9.
Carella, Angelo Michele, Germana Beltrami, Maria Teresa Corsetti, et al.. (2005). Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer. The Lancet. 366(9482). 318–320. 41 indexed citations
10.
Ballestrero, Alberto, Filippo Montemurro, Roberta Gonella, et al.. (2003). Dose-dense Vinorelbine and Paclitaxel with Granulocyte Colony-stimulating Factor in Metastatic Breast Cancer Patients: Anti-tumor Activity and Peripheral Blood Progenitor Cell Mobilization Capability. Breast Cancer Research and Treatment. 82(3). 185–190. 8 indexed citations
11.
Ballestrero, Alberto, Fabio Ferrando, Maurizio Miglino, et al.. (2002). Three‐step high‐dose sequential chemotherapy in patients with newly diagnosed multiple myeloma. European Journal Of Haematology. 68(2). 101–106. 4 indexed citations
12.
Ballestrero, Alberto, Domenico Coviello, Anna Garuti, et al.. (2001). Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. Cancer. 92(8). 2030–2035. 18 indexed citations
13.
Ballestrero, Alberto, Fabio Ferrando, Anna Garuti, et al.. (2000). Effects of Three Cytokine Regimens on Hematologic Recovery and Progenitor Cell Mobilization after High-Dose Cyclophosphamide, Etoposide, and Cisplatin. Oncology. 59(1). 7–13. 3 indexed citations
14.
Ballestrero, Alberto, Marino Clavio, Roberta Gonella, et al.. (2000). High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma.. International Journal of Oncology. 17(5). 1007–13. 9 indexed citations
16.
Ottonello, Luciano, Roberta Gonella, Patrizia Dapino, C. Sacchetti, & Franco Dallegri. (1998). Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: role of intracellular cyclic AMP levels.. PubMed. 26(9). 895–902. 54 indexed citations
17.
Ballestrero, Alberto, Fabio Ferrando, Anna Garuti, et al.. (1997). High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule. British Journal of Cancer. 76(6). 797–804. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026